As of 2026, neither compound has FDA approval, limiting prescribing to research contexts or off-label use by physicians specializing in obesity medicine or endocrinology
However, there are significant safety considerations and clinical steps to navigate first
Within the repair category, BPC-157 can be compared with TB-500 and the BPC-157 + TB-500 blend where those public records are available
A slight blip might not mean much, but a consistent upward trend in creatinine or a downward trend in eGFR is what your healthcare provider will pay attention to
Uhles S, Wang H, Bnardeau A, Prummer M, Brecheisen M, Sewing S, Tobalina L, Bosco D, Wollheim CB, Migliorini C